integrinβ1 (Galectin Therapeutics)
Structured Review

Integrinβ1, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/integrin%CE%B21/pmc12579083-172-3-5?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Effect of fibrinogen like protein 1 on cisplatin-resistance in laryngeal carcinoma through targeting integrinβ1 in vivo and in vitro"
Article Title: Effect of fibrinogen like protein 1 on cisplatin-resistance in laryngeal carcinoma through targeting integrinβ1 in vivo and in vitro
Journal: Discover Oncology
doi: 10.1007/s12672-025-03337-x
Figure Legend Snippet: Integrinβ1 affected CDDP resistance and was regulated by FGL1 in TU212-R cells. A The expression of FGL1 and Integrinβ1 in NP69, TU212 and TU212-R cells was detected by western blot assay. B The cell viability of TU212-R cells was assessed after FGL1 knockdown and treatmentwith Pyrintegrin. C , D Expression levels of FGL1 and Integrinβ1 in TU212-R cellsafter FGL1 knockdown and treatmentwith Pyrintegrin. Grey values were analyzed by Image J software, with expression normalized to GAPDH, n=3.ns indicates no significant difference, ** P < 0.01, *** P < 0.001.
Techniques Used: Expressing, Western Blot, Knockdown, Software
Figure Legend Snippet: Downregulation of FGL1 inhibited the migration and invasion abilities of TU212-R cells through regulating Integrinβ1. The migration and invasion abilities of TU212-R cells were determined by wound healing assay (scale bar: 50 μm) (A) and transwell assay (scale bar: 50 μm) (B) after FGL1 knockdown and treatment with Pyrintegrin. n=3, ns means no significant difference, ** P < 0.01, *** P < 0.001.
Techniques Used: Migration, Wound Healing Assay, Transwell Assay, Knockdown
Figure Legend Snippet: Tumorigenicity of TU212-R in vivo. A Representative images of mice bearing TU212-R tumors from different treatment groups. The tumor volume growth curves ( B ) over the study period and the tumor weight ( C ) after injections of different treatment groups. D Immunohistochemical staining for Ki67, FGL1, Integrinβ1 and P-gp proteins in different xenograft tumor tissues (scale bar: 100 μm). The positive area was quantified by Image J software. n = 5, ns means no significant difference, * P < 0.05, ** P < 0.01, *** P < 0.001
Techniques Used: In Vivo, Immunohistochemical staining, Staining, Software
Figure Legend Snippet: The expression of Integrinβ1 and resistance proteins regulated by FGL1 affected apoptosis in vivo. (A) Representative images of TUNEL staining in different xenograft tumor tissues (scale bar: 200 μm). (B) The apoptosis incidence was measured by Image J software. (C) Expression levels of FGL1, Integrinβ1, MRP1 and P-gp in different xenograft tumor tissues were evaluated by western blot assay. n=5, ns indicates no significant difference, * P < 0.05, ** P < 0.01, *** P < 0.001.
Techniques Used: Expressing, In Vivo, TUNEL Assay, Staining, Software, Western Blot

